MenBiovax

N/A

Report date: 2025/03/20 14:51:48

Base Information

Drug NameMenBiovax
Drug Alias NameNeisseria meningitidis B vaccine (ImmBio/Health Protection Agency)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsNeisseriaceae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunobiology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHealth Protection AgencyImmunobiology Ltd
Inactive CompaniesN/A
Active IndicationsNeisseriaceae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A